Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-UK detects South African coronavirus variant in people with no travel links

Mon, 01st Feb 2021 12:28

(Adds further details, reaction)

By Paul Sandle

LONDON, Feb 1 (Reuters) - Eleven people in different regions
of England have tested positive for the South African
coronavirus variant without having any links to people who have
travelled, prompting mass testing in the areas to contain the
outbreak.

Britain, with the fifth-highest COVID-19 death toll in the
world, has moved to tighten its borders out of concern that new
variants of the virus will undermine its vaccination drive.

To contain the new outbreaks, residents in eight areas of
the country will now be tested whether or not they are showing
any symptoms, a process known as "surge testing".

There are about 10,000 people in each area. Three are in
London, two in the southeast, one in central England, one in the
east and another in the northwest.

The government said on Monday the 11 cases were
self-isolating and contact tracing would help to halt the
spread.

Positive tests in the areas will be sequenced to identify
any further spread of the South African variant, the government
statement said.

All viruses mutate, and scientists have identified several
variants of the coronavirus found to be more transmissible than
the original strain.

Their emergence has raised questions over whether vaccines
will prove as effective in containing them.

Britain said on Jan. 24 it had detected 77 cases of the
South African variant and nine cases of the Brazilian variant,
but said all were linked to travel.

In total, Public Health England said it had now identified
105 cases of the South African variant since Dec 22.

Scientists have said the South African variant appears to be
more transmissible, but there is no evidence it causes more
severe disease. But several laboratory studies have found that
it reduces vaccine and antibody therapy efficacy.

Simon Clarke, associate professor in cellular microbiology
at the University of Reading, said there was emerging evidence
to suggest the variant was less susceptible to immunity induced
by the current crop of vaccines.

"The discovery of a handful of cases with no links to travel
to Africa, indicates that it might be more widespread in the
community than previously thought," he said.

"This spread, even if small in scale, needs to be brought
under control quickly, so Public Health England's house-to-house
checks, and intensive testing are the right thing to do."

Britain is battling a new wave of COVID-19 turbo-charged by
the emergence in September of a more transmittable variant found
in the southeast of England. The country's official death toll
passed 100,000 last week.
Britain is however making rapid progress in its vaccination
programme, with nearly 9 million people receiving the first shot
of either the Pfizer-BioNTech or the Oxford-AstraZeneca shot.
(Reporting by Kate Holton, Michael Holden and Paul Sandle;
Editing by Estelle Shirbon and Timothy Heritage)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.